Kai Liu

5.2k total citations · 1 hit paper
192 papers, 3.8k citations indexed

About

Kai Liu is a scholar working on Molecular Biology, Plant Science and Materials Chemistry. According to data from OpenAlex, Kai Liu has authored 192 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Molecular Biology, 35 papers in Plant Science and 21 papers in Materials Chemistry. Recurrent topics in Kai Liu's work include Advanced Nanomaterials in Catalysis (18 papers), Pharmacological Effects of Natural Compounds (11 papers) and Advanced biosensing and bioanalysis techniques (11 papers). Kai Liu is often cited by papers focused on Advanced Nanomaterials in Catalysis (18 papers), Pharmacological Effects of Natural Compounds (11 papers) and Advanced biosensing and bioanalysis techniques (11 papers). Kai Liu collaborates with scholars based in China, United States and France. Kai Liu's co-authors include Xiaofang Li, Long Xie, Jiaying Long, Youdan Liang, Xiaolin Dai, Xumin Zhang, Yu Zheng, Yi Cao, Huijuan Chen and Jing Lu and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and SHILAP Revista de lepidopterología.

In The Last Decade

Kai Liu

181 papers receiving 3.7k citations

Hit Papers

Signaling pathways in vascular function and hypertension:... 2023 2026 2024 2025 2023 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kai Liu China 34 1.5k 650 353 309 300 192 3.8k
Xiaoke Zheng China 31 2.1k 1.4× 756 1.2× 321 0.9× 326 1.1× 254 0.8× 343 4.3k
Dongli Li China 30 1.3k 0.8× 554 0.9× 281 0.8× 549 1.8× 206 0.7× 255 4.0k
Mei Jing Piao South Korea 40 2.1k 1.4× 533 0.8× 677 1.9× 459 1.5× 287 1.0× 159 5.4k
Amjad Ali Khan Saudi Arabia 36 1.2k 0.8× 616 0.9× 246 0.7× 308 1.0× 158 0.5× 89 3.5k
Yulin Feng China 35 2.0k 1.3× 683 1.1× 484 1.4× 350 1.1× 160 0.5× 231 4.2k
Je‐Hyuk Lee South Korea 21 1.8k 1.2× 510 0.8× 301 0.9× 243 0.8× 247 0.8× 84 4.7k
Lusânia Maria Greggi Antunes Brazil 38 1.3k 0.8× 689 1.1× 310 0.9× 335 1.1× 202 0.7× 161 4.3k
Chi‐Feng Hung Taiwan 41 1.3k 0.9× 380 0.6× 295 0.8× 358 1.2× 177 0.6× 132 4.4k
Ravirajsinh N. Jadeja United States 31 985 0.6× 450 0.7× 455 1.3× 169 0.5× 252 0.8× 102 3.2k
Yongping Bao United Kingdom 37 2.7k 1.8× 897 1.4× 355 1.0× 367 1.2× 232 0.8× 111 5.9k

Countries citing papers authored by Kai Liu

Since Specialization
Citations

This map shows the geographic impact of Kai Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai Liu more than expected).

Fields of papers citing papers by Kai Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kai Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai Liu. The network helps show where Kai Liu may publish in the future.

Co-authorship network of co-authors of Kai Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Kai Liu. A scholar is included among the top collaborators of Kai Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kai Liu. Kai Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Liu, Kai, Haoran Li, Alan K. Chang, et al.. (2025). Evaluation of the Safety of Fenbuconazole Monomers via Enantioselective Toxicokinetics, Molecular Docking and Enantiomer Conversion Analyses. Journal of Agricultural and Food Chemistry. 73(16). 9894–9905. 1 indexed citations
3.
Liu, Kai, et al.. (2025). A Low-Intensity Nutrition Intervention Targeting Triglycerides in Gestational Diabetes: A Feasibility RCT. The Journal of Clinical Endocrinology & Metabolism. 111(1). 218–228.
4.
Liu, Kai, Xiaoyi Hu, Qiuli He, et al.. (2025). Decreased excitatory and increased inhibitory transmission in the hippocampal CA1 drive neuroinflammation-induced cognitive impairments in mice. Brain Behavior and Immunity. 128. 416–428. 3 indexed citations
5.
Li, Jianxin, Alan K. Chang, Ying Pei, et al.. (2024). Toxicokinetics and bioavailability of indoxacarb enantiomers and their new metabolites in rats. Pesticide Biochemistry and Physiology. 203. 106024–106024. 4 indexed citations
8.
Liu, Xing, et al.. (2024). Preparation and characterisation of silybin nanoemulsions based on complex emulsifiers: stability, in vitro release properties and antioxidant capacity. International Journal of Food Science & Technology. 59(5). 3331–3339. 1 indexed citations
9.
Zhao, Bolin, et al.. (2024). Plant‐derived flavonoids are a potential source of drugs for the treatment of liver fibrosis. Phytotherapy Research. 38(6). 3122–3145. 18 indexed citations
10.
Liu, Kai, Yulin Wang, Jing Lin, et al.. (2024). Target-Engineered Liposomes Decorated with Nanozymes Alleviate Liver Fibrosis by Remodeling the Liver Microenvironment. ACS Applied Materials & Interfaces. 16(47). 64536–64553. 6 indexed citations
11.
Liu, Kai, et al.. (2024). Cryptotanshinone-loaded biomimetic pH-sensitive liposomes for the treatment of liver fibrosis. Journal of Drug Delivery Science and Technology. 104. 106496–106496. 1 indexed citations
12.
Gu, Wan‐Jie, et al.. (2023). Cannabinoid receptor 2 alleviates sepsis-associated acute lung injury by modulating maturation of dendritic cells. International Immunopharmacology. 123. 110771–110771. 3 indexed citations
14.
Lu, Jing, Kai Liu, Long Xie, et al.. (2023). Hypericin as a promising natural bioactive naphthodianthrone: A review of its pharmacology, pharmacokinetics, toxicity, and safety. Phytotherapy Research. 37(12). 5639–5656. 15 indexed citations
15.
Zheng, Yu, Kai Liu, Youdan Liang, et al.. (2023). Lignans as multi‐targeted natural products in neurodegenerative diseases and depression: Recent perspectives. Phytotherapy Research. 37(12). 5599–5621. 13 indexed citations
16.
Liu, Kai, et al.. (2023). Extraction process, physicochemical properties, and digestive performance of red yeast rice starch. Biotechnology and Applied Biochemistry. 71(2). 372–386. 1 indexed citations
17.
Wang, Xian, Jing Lu, Yi Cao, et al.. (2023). Does binary blend emulsifier enhance emulsifier performance? Preparation of baicalin nanoemulsions using tea saponins and glycyrrhizic acid as binary blend emulsifier. Journal of Drug Delivery Science and Technology. 84. 104398–104398. 11 indexed citations
19.
Liu, Kai, et al.. (2021). Ultrasonic extraction, structural characterization, and antioxidant activity of oligosaccharides from red yeast rice. Food Science & Nutrition. 10(1). 204–217. 13 indexed citations
20.
Chen, Huijuan, Mao Deng, Long Xie, et al.. (2021). Preparation and characterization of quercetin nanosuspensions using gypenosides as novel stabilizers. Journal of Drug Delivery Science and Technology. 67. 102962–102962. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026